Table of Contents Solid Tumors Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Solid Tumors Drugs 1.1 Solid Tumors Drugs Market Overview 1.1.1 Solid Tumors Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Solid Tumors Drugs Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Solid Tumors Drugs Market by Type 1.3.1 Global Solid Tumors Drugs Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Solid Tumors Drugs Revenue Market Share by Type in 2018 1.3.3 Small Molecules 1.3.4 Biologics 1.4 Solid Tumors Drugs Market by End Users/Application 1.4.1 Hospitals 1.4.2 Clinics 1.4.3 Academic and Research Institutes 2 Global Solid Tumors Drugs Competition Analysis by Players 2.1 Global Solid Tumors Drugs Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 Hoffmann-La Roche 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Celgene 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Johnson & Johnson 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Pfizer 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 BMS 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Eli Lilly 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 GSK 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Merck 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Sanofi 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Solid Tumors Drugs Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 AbbVie 3.12 AstraZeneca 3.13 Bayer 3.14 Biogen 3.15 Boehringer Ingelheim 3.16 Boston Biomedical 3.17 Daiichi Sankyo 4 Global Solid Tumors Drugs Market Size by Type and Application (2014-2019) 4.1 Global Solid Tumors Drugs Market Size by Type (2014-2019) 4.2 Global Solid Tumors Drugs Market Size by Application (2014-2019) 4.3 Potential Application of Solid Tumors Drugs in Future 4.4 Top Consumer/End Users of Solid Tumors Drugs 5 North America Solid Tumors Drugs Development Status and Outlook 5.1 North America Solid Tumors Drugs Market Size (2014-2019) 5.2 North America Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 5.3 North America Solid Tumors Drugs Market Size by Application (2014-2019) 6 Europe Solid Tumors Drugs Development Status and Outlook 6.1 Europe Solid Tumors Drugs Market Size (2014-2019) 6.2 Europe Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 6.3 Europe Solid Tumors Drugs Market Size by Application (2014-2019) 7 China Solid Tumors Drugs Development Status and Outlook 7.1 China Solid Tumors Drugs Market Size (2014-2019) 7.2 China Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 7.3 China Solid Tumors Drugs Market Size by Application (2014-2019) 8 Rest of Asia Pacific Solid Tumors Drugs Development Status and Outlook 8.1 Rest of Asia Pacific Solid Tumors Drugs Market Size (2014-2019) 8.2 Rest of Asia Pacific Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Solid Tumors Drugs Market Size by Application (2014-2019) 9 Central & South America Solid Tumors Drugs Development Status and Outlook 9.1 Central & South America Solid Tumors Drugs Market Size (2014-2019) 9.2 Central & South America Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Solid Tumors Drugs Market Size by Application (2014-2019) 10 Middle East & Africa Solid Tumors Drugs Development Status and Outlook 10.1 Middle East & Africa Solid Tumors Drugs Market Size (2014-2019) 10.2 Middle East & Africa Solid Tumors Drugs Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Solid Tumors Drugs Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Solid Tumors Drugs Market Size by Regions (2019-2025) 11.1.1 North America Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.1.2 Europe Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.1.3 China Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Solid Tumors Drugs Revenue and Growth Rate (2019-2025) 11.2 Global Solid Tumors Drugs Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Solid Tumors Drugs Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Solid Tumors Drugs Market Size (Million USD) Status and Outlook (2014-2025) Table Global Solid Tumors Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Solid Tumors Drugs Market Share by Regions (2014-2019) Figure North America Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure China Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Solid Tumors Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Solid Tumors Drugs Market Share by Type in 2018 & 2025 Figure Small Molecules Market Size (Million USD) and Growth Rate (2014-2019) Figure Biologics Market Size (Million USD) and Growth Rate (2014-2019) Table Global Solid Tumors Drugs Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Solid Tumors Drugs Market Share by Application in 2018 & 2025 Figure Solid Tumors Drugs Market Size (Million USD) and Growth Rate in Hospitals (2014-2019) Figure Solid Tumors Drugs Market Size (Million USD) and Growth Rate in Clinics (2014-2019) Figure Solid Tumors Drugs Market Size (Million USD) and Growth Rate in Academic and Research Institutes (2014-2019) Table Global Solid Tumors Drugs Revenue (Million US$) by Players (2014-2019) Table Global Solid Tumors Drugs Revenue Market Share by Players (2014-2019) Eigure Solid Tumors Drugs Market Size Share by Players in 2018 Table Global Solid Tumors Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Solid Tumors Drugs Market Share in 2018 Figure Global Top 10 Players Solid Tumors Drugs Market Share in 2018 Table Solid Tumors Drugs Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table Hoffmann-La Roche Basic Information List Table Hoffmann-La Roche Description and Business Overview Table Hoffmann-La Roche Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Hoffmann-La Roche (2014-2019) Table Hoffmann-La Roche Solid Tumors Drugs Recent Developments Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Novartis (2014-2019) Table Novartis Solid Tumors Drugs Recent Developments Table Celgene Basic Information List Table Celgene Description and Business Overview Table Celgene Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Celgene (2014-2019) Table Celgene Solid Tumors Drugs Recent Developments Table Johnson & Johnson Basic Information List Table Johnson & Johnson Description and Business Overview Table Johnson & Johnson Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Johnson & Johnson (2014-2019) Table Johnson & Johnson Solid Tumors Drugs Recent Developments Table Pfizer Basic Information List Table Pfizer Description and Business Overview Table Pfizer Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Pfizer (2014-2019) Table Pfizer Solid Tumors Drugs Recent Developments Table BMS Basic Information List Table BMS Description and Business Overview Table BMS Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of BMS (2014-2019) Table BMS Solid Tumors Drugs Recent Developments Table Eli Lilly Basic Information List Table Eli Lilly Description and Business Overview Table Eli Lilly Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Eli Lilly (2014-2019) Table Eli Lilly Solid Tumors Drugs Recent Developments Table GSK Basic Information List Table GSK Description and Business Overview Table GSK Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of GSK (2014-2019) Table GSK Solid Tumors Drugs Recent Developments Table Merck Basic Information List Table Merck Description and Business Overview Table Merck Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Merck (2014-2019) Table Merck Solid Tumors Drugs Recent Developments Table Sanofi Basic Information List Table Sanofi Description and Business Overview Table Sanofi Solid Tumors Drugs Products, Services and Solutions Table Revenue (Million US$) in Solid Tumors Drugs Business of Sanofi (2014-2019) Table Sanofi Solid Tumors Drugs Recent Developments Table AbbVie Basic Information List Table AstraZeneca Basic Information List Table Bayer Basic Information List Table Biogen Basic Information List Table Boehringer Ingelheim Basic Information List Table Boston Biomedical Basic Information List Table Daiichi Sankyo Basic Information List Table Global Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$) Figure Global Solid Tumors Drugs Revenue Market Share by Type in 2018 Table Global Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure Global Solid Tumors Drugs Revenue Market by Application in 2018 Table Top Consumer/End Users of Solid Tumors Drugs Figure North America Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table North America Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure North America Solid Tumors Drugs Market Size Share by Players in 2018 Table North America Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure North America Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure North America Solid Tumors Drugs Market Size Share by Application in 2018 Figure Europe Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure Europe Solid Tumors Drugs Market Size Share by Players in 2018 Table Europe Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure Europe Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure Europe Solid Tumors Drugs Market Size Share by Application in 2018 Figure China Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table China Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure China Solid Tumors Drugs Market Size Share by Players in 2018 Table China Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure China Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure China Solid Tumors Drugs Market Size Share by Application in 2018 Figure Rest of Asia Pacific Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Solid Tumors Drugs Market Size Share by Players in 2018 Table Rest of Asia Pacific Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Solid Tumors Drugs Market Size Share by Application in 2018 Figure Central & South America Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure Central & South America Solid Tumors Drugs Market Size Share by Players in 2018 Table Central & South America Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure Central & South America Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure Central & South America Solid Tumors Drugs Market Size Share by Application in 2018 Figure Middle East & Africa Solid Tumors Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Solid Tumors Drugs Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Solid Tumors Drugs Market Size Share by Players in 2018 Table Middle East & Africa Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Solid Tumors Drugs Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Solid Tumors Drugs Market Size Share by Application in 2018 Figure Global Solid Tumors Drugs Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Solid Tumors Drugs Market Size by Regions (2019-2025) (Million US$) Figure Global Solid Tumors Drugs Market Size Share by Regions (2019-2025) Figure Global Solid Tumors Drugs Market Size Share by Regions in 2025 Figure North America Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure China Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2019-2025) Table Global Solid Tumors Drugs Market Size by Application (2019-2025) (Million USD) Figure Global Solid Tumors Drugs Market Size by Application (2019-2025) Figure Global Solid Tumors Drugs Market Size by Application in 2025 Table Global Solid Tumors Drugs Market Size by Type (2019-2025) (Million US$) Figure Global Solid Tumors Drugs Market Size by Type (2019-2025) Figure Global Solid Tumors Drugs Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Hoffmann-La Roche Novartis Celgene Johnson & Johnson Pfizer BMS Eli Lilly GSK Merck Sanofi AbbVie AstraZeneca Bayer Biogen Boehringer Ingelheim Boston Biomedical Daiichi Sankyo